APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaccines For Children

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vaccines For Children Market Analysis and Forecast 2026-2032

Report ID 174044880219 December 2025192 pages

Choose your research edition.

Industry ResearchVaccines For Children Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccines For Children Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Vaccines For Children Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccines For Children Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccines For Children Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Vaccines For Children market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vaccines For Children is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vaccines For Children is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vaccines For Children is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vaccines For Children is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vaccines For Children include GSK, CSL, Hissen, J&J(Crucell), Jintan, MedImmune LLC, Tiantan, Hualan and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vaccines For Children, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vaccines For Children, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccines For Children, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccines For Children sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vaccines For Children market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vaccines For Children sales, projected growth trends, production technology, application and end-user industry.

Vaccines For Children Segment by Company

GSK

CSL

Hissen

J&J(Crucell)

Jintan

MedImmune LLC

Tiantan

Hualan

Pfizer

Kangtai

Merck

Sanofi

China National Biotec

Vaccines For Children Segment by Type

Recombinant Vaccines

Polysaccharide Vaccines

Viral Vaccines

Others

Vaccines For Children Segment by Application

Hospital

Clinic

Vaccines For Children Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines For Children market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccines For Children and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines For Children.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vaccines For Children in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vaccines For Children manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccines For Children sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaccines For Children Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Vaccines Major Manufacturers Table 3. Polysaccharide Vaccines Major Manufacturers Table 4. Viral Vaccines Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Vaccines For Children Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Vaccines For Children Industry Trends Table 10. Vaccines For Children Industry Drivers Table 11. Vaccines For Children Industry Opportunities and Challenges Table 12. Vaccines For Children Industry Restraints Table 13. Global Vaccines For Children Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Vaccines For Children Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Vaccines For Children Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Vaccines For Children Revenue Market Share by Region (2021-2026) Table 17. Global Vaccines For Children Revenue Market Share by Region (2027-2032) Table 18. Global Vaccines For Children Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Doses) Table 19. Global Vaccines For Children Sales by Region (2021-2026) & (K Doses) Table 20. Global Vaccines For Children Sales by Region (2027-2032) & (K Doses) Table 21. Global Vaccines For Children Sales Market Share by Region (2021-2026) Table 22. Global Vaccines For Children Sales Market Share by Region (2027-2032) Table 23. Global Vaccines For Children Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Vaccines For Children Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Vaccines For Children Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Vaccines For Children Sales Market Share by Manufacturers (2021-2026) Table 27. Global Vaccines For Children Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 28. Global Vaccines For Children Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Vaccines For Children Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Vaccines For Children Manufacturers, Product Type & Application Table 31. Global Vaccines For Children Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Vaccines For Children by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Vaccines For Children Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Vaccines For Children Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Vaccines For Children Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Vaccines For Children Revenue Market Share by Type (2021-2026) Table 38. Global Vaccines For Children Revenue Market Share by Type (2027-2032) Table 39. Global Vaccines For Children Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 40. Global Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 41. Global Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 42. Global Vaccines For Children Sales Market Share by Type (2021-2026) Table 43. Global Vaccines For Children Sales Market Share by Type (2027-2032) Table 44. Global Vaccines For Children Price by Type (2021-2026) & (US$/Dose) Table 45. Global Vaccines For Children Price by Type (2027-2032) & (US$/Dose) Table 46. Global Vaccines For Children Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Vaccines For Children Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Vaccines For Children Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Vaccines For Children Revenue Market Share by Application (2021-2026) Table 50. Global Vaccines For Children Revenue Market Share by Application (2027-2032) Table 51. Global Vaccines For Children Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 52. Global Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 53. Global Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 54. Global Vaccines For Children Sales Market Share by Application (2021-2026) Table 55. Global Vaccines For Children Sales Market Share by Application (2027-2032) Table 56. Global Vaccines For Children Price by Application (2021-2026) & (US$/Dose) Table 57. Global Vaccines For Children Price by Application (2027-2032) & (US$/Dose) Table 58. GSK Company Information Table 59. GSK Business Overview Table 60. GSK Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 61. GSK Vaccines For Children Product Portfolio Table 62. GSK Recent Development Table 63. CSL Company Information Table 64. CSL Business Overview Table 65. CSL Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 66. CSL Vaccines For Children Product Portfolio Table 67. CSL Recent Development Table 68. Hissen Company Information Table 69. Hissen Business Overview Table 70. Hissen Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 71. Hissen Vaccines For Children Product Portfolio Table 72. Hissen Recent Development Table 73. J&J(Crucell) Company Information Table 74. J&J(Crucell) Business Overview Table 75. J&J(Crucell) Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 76. J&J(Crucell) Vaccines For Children Product Portfolio Table 77. J&J(Crucell) Recent Development Table 78. Jintan Company Information Table 79. Jintan Business Overview Table 80. Jintan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 81. Jintan Vaccines For Children Product Portfolio Table 82. Jintan Recent Development Table 83. MedImmune LLC Company Information Table 84. MedImmune LLC Business Overview Table 85. MedImmune LLC Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 86. MedImmune LLC Vaccines For Children Product Portfolio Table 87. MedImmune LLC Recent Development Table 88. Tiantan Company Information Table 89. Tiantan Business Overview Table 90. Tiantan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 91. Tiantan Vaccines For Children Product Portfolio Table 92. Tiantan Recent Development Table 93. Hualan Company Information Table 94. Hualan Business Overview Table 95. Hualan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 96. Hualan Vaccines For Children Product Portfolio Table 97. Hualan Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 101. Pfizer Vaccines For Children Product Portfolio Table 102. Pfizer Recent Development Table 103. Kangtai Company Information Table 104. Kangtai Business Overview Table 105. Kangtai Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 106. Kangtai Vaccines For Children Product Portfolio Table 107. Kangtai Recent Development Table 108. Merck Company Information Table 109. Merck Business Overview Table 110. Merck Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 111. Merck Vaccines For Children Product Portfolio Table 112. Merck Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 116. Sanofi Vaccines For Children Product Portfolio Table 117. Sanofi Recent Development Table 118. China National Biotec Company Information Table 119. China National Biotec Business Overview Table 120. China National Biotec Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 121. China National Biotec Vaccines For Children Product Portfolio Table 122. China National Biotec Recent Development Table 123. North America Vaccines For Children Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Vaccines For Children Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 126. North America Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 127. North America Vaccines For Children Sales Price by Type (2021-2026) & (US$/Dose) Table 128. North America Vaccines For Children Sales Price by Type (2027-2032) & (US$/Dose) Table 129. North America Vaccines For Children Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Vaccines For Children Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 132. North America Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 133. North America Vaccines For Children Sales Price by Application (2021-2026) & (US$/Dose) Table 134. North America Vaccines For Children Sales Price by Application (2027-2032) & (US$/Dose) Table 135. North America Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Vaccines For Children Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Vaccines For Children Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Vaccines For Children Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 139. North America Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 140. North America Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 141. North America Vaccines For Children Sales Price by Country (2021-2026) & (US$/Dose) Table 142. North America Vaccines For Children Sales Price by Country (2027-2032) & (US$/Dose) Table 143. United States Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 144. Canada Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 145. Europe Vaccines For Children Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Vaccines For Children Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 148. Europe Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 149. Europe Vaccines For Children Sales Price by Type (2021-2026) & (US$/Dose) Table 150. Europe Vaccines For Children Sales Price by Type (2027-2032) & (US$/Dose) Table 151. Europe Vaccines For Children Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Vaccines For Children Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 154. Europe Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 155. Europe Vaccines For Children Sales Price by Application (2021-2026) & (US$/Dose) Table 156. Europe Vaccines For Children Sales Price by Application (2027-2032) & (US$/Dose) Table 157. Europe Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Vaccines For Children Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Vaccines For Children Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Vaccines For Children Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 161. Europe Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 162. Europe Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 163. Europe Vaccines For Children Sales Price by Country (2021-2026) & (US$/Dose) Table 164. Europe Vaccines For Children Sales Price by Country (2027-2032) & (US$/Dose) Table 165. Germany Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 166. France Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 167. U.K. Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 168. Italy Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 169. Netherlands Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 170. China Vaccines For Children Revenue by Type (2021-2026) & (US$ Million) Table 171. China Vaccines For Children Revenue by Type (2027-2032) & (US$ Million) Table 172. China Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 173. China Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 174. China Vaccines For Children Sales Price by Type (2021-2026) & (US$/Dose) Table 175. China Vaccines For Children Sales Price by Type (2027-2032) & (US$/Dose) Table 176. China Vaccines For Children Revenue by Application (2021-2026) & (US$ Million) Table 177. China Vaccines For Children Revenue by Application (2027-2032) & (US$ Million) Table 178. China Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 179. China Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 180. China Vaccines For Children Sales Price by Application (2021-2026) & (US$/Dose) Table 181. China Vaccines For Children Sales Price by Application (2027-2032) & (US$/Dose) Table 182. Asia Vaccines For Children Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Vaccines For Children Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 185. Asia Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 186. Asia Vaccines For Children Sales Price by Type (2021-2026) & (US$/Dose) Table 187. Asia Vaccines For Children Sales Price by Type (2027-2032) & (US$/Dose) Table 188. Asia Vaccines For Children Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Vaccines For Children Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 191. Asia Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 192. Asia Vaccines For Children Sales Price by Application (2021-2026) & (US$/Dose) Table 193. Asia Vaccines For Children Sales Price by Application (2027-2032) & (US$/Dose) Table 194. Asia Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Vaccines For Children Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Vaccines For Children Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Vaccines For Children Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 198. Asia Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 199. Asia Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 200. Asia Vaccines For Children Sales Price by Country (2021-2026) & (US$/Dose) Table 201. Asia Vaccines For Children Sales Price by Country (2027-2032) & (US$/Dose) Table 202. Japan Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 203. South Korea Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 204. India Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 205. Australia Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 206. China Taiwan Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Vaccines For Children Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Vaccines For Children Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 211. SAMEA Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 212. SAMEA Vaccines For Children Sales Price by Type (2021-2026) & (US$/Dose) Table 213. SAMEA Vaccines For Children Sales Price by Type (2027-2032) & (US$/Dose) Table 214. SAMEA Vaccines For Children Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Vaccines For Children Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 217. SAMEA Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 218. SAMEA Vaccines For Children Sales Price by Application (2021-2026) & (US$/Dose) Table 219. SAMEA Vaccines For Children Sales Price by Application (2027-2032) & (US$/Dose) Table 220. SAMEA Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Vaccines For Children Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Vaccines For Children Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Vaccines For Children Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 224. SAMEA Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 225. SAMEA Vaccines For Children Sales by Country (2027-2032) & (K Doses) Table 226. SAMEA Vaccines For Children Sales Price by Country (2021-2026) & (US$/Dose) Table 227. SAMEA Vaccines For Children Sales Price by Country (2027-2032) & (US$/Dose) Table 228. Brazil Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 229. Argentina Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 230. Chile Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 231. Colombia Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 232. Peru Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 234. Israel Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 235. UAE Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 236. Turkey Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 237. Iran Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 238. Egypt Vaccines For Children Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Vaccines For Children Distributors List Table 242. Vaccines For Children Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Vaccines For Children Image Figure 2. Global Vaccines For Children Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccines For Children Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Vaccines Image Figure 5. Polysaccharide Vaccines Image Figure 6. Viral Vaccines Image Figure 7. Others Image Figure 8. Global Vaccines For Children Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Vaccines For Children Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Vaccines For Children Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Vaccines For Children Revenue (2021-2032) & (US$ Million) Figure 14. Global Vaccines For Children Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Vaccines For Children Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Vaccines For Children Revenue Market Share by Region (2021-2032) Figure 17. Global Vaccines For Children Sales (2021-2032) & (K Doses) Figure 18. Global Vaccines For Children Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Figure 19. Global Vaccines For Children Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Vaccines For Children Sales YoY (2021-2032) & (K Doses) Figure 21. Europe Vaccines For Children Sales YoY (2021-2032) & (K Doses) Figure 22. China Vaccines For Children Sales YoY (2021-2032) & (K Doses) Figure 23. Asia (Excluding China) Vaccines For Children Sales YoY (2021-2032) & (K Doses) Figure 24. South America, Middle East and Africa Vaccines For Children Sales YoY (2021-2032) & (K Doses) Figure 25. Global Vaccines For Children Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Vaccines For Children Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Vaccines For Children Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Vaccines For Children Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Vaccines For Children Revenue Market Share by Type (2021-2032) Figure 31. Global Vaccines For Children Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 32. Global Vaccines For Children Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Vaccines For Children Sales Market Share by Type (2021-2032) Figure 34. Global Vaccines For Children Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Vaccines For Children Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Vaccines For Children Revenue Market Share by Application (2021-2032) Figure 37. Global Vaccines For Children Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 38. Global Vaccines For Children Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Vaccines For Children Sales Market Share by Application (2021-2032) Figure 40. North America Vaccines For Children Revenue Share by Type (2021-2032) Figure 41. North America Vaccines For Children Sales Share by Type (2021-2032) Figure 42. North America Vaccines For Children Revenue Share by Application (2021-2032) Figure 43. North America Vaccines For Children Sales Share by Application (2021-2032) Figure 44. North America Vaccines For Children Revenue Share by Country (2021-2032) Figure 45. North America Vaccines For Children Sales Share by Country (2021-2032) Figure 46. Europe Vaccines For Children Revenue Share by Type (2021-2032) Figure 47. Europe Vaccines For Children Sales Share by Type (2021-2032) Figure 48. Europe Vaccines For Children Revenue Share by Application (2021-2032) Figure 49. Europe Vaccines For Children Sales Share by Application (2021-2032) Figure 50. Europe Vaccines For Children Revenue Share by Country (2021-2032) Figure 51. Europe Vaccines For Children Sales Share by Country (2021-2032) Figure 52. China Vaccines For Children Revenue Share by Type (2021-2032) Figure 53. China Vaccines For Children Sales Share by Type (2021-2032) Figure 54. China Vaccines For Children Revenue Share by Application (2021-2032) Figure 55. China Vaccines For Children Sales Share by Application (2021-2032) Figure 56. Asia Vaccines For Children Revenue Share by Type (2021-2032) Figure 57. Asia Vaccines For Children Sales Share by Type (2021-2032) Figure 58. Asia Vaccines For Children Revenue Share by Application (2021-2032) Figure 59. Asia Vaccines For Children Sales Share by Application (2021-2032) Figure 60. Asia Vaccines For Children Revenue Share by Country (2021-2032) Figure 61. Asia Vaccines For Children Sales Share by Country (2021-2032) Figure 62. SAMEA Vaccines For Children Revenue Share by Type (2021-2032) Figure 63. SAMEA Vaccines For Children Sales Share by Type (2021-2032) Figure 64. SAMEA Vaccines For Children Revenue Share by Application (2021-2032) Figure 65. SAMEA Vaccines For Children Sales Share by Application (2021-2032) Figure 66. SAMEA Vaccines For Children Revenue Share by Country (2021-2032) Figure 67. SAMEA Vaccines For Children Sales Share by Country (2021-2032) Figure 68. Vaccines For Children Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Vaccines For Children Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Polysaccharide Vaccines
  • Viral Vaccines
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK
  • CSL
  • Hissen
  • J&J(Crucell)
  • Jintan
  • MedImmune LLC
  • Tiantan
  • Hualan
  • Pfizer
  • Kangtai
  • Merck
  • Sanofi
  • China National Biotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vaccines For Children Market by Type
  3. 1.2.1 Global Vaccines For Children Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Vaccines
  5. 1.2.3 Polysaccharide Vaccines
  6. 1.2.4 Viral Vaccines
  7. 1.2.5 Others
  8. 1.3 Vaccines For Children Market by Application
  9. 1.3.1 Global Vaccines For Children Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Vaccines For Children Market Dynamics
  1. 2.1 Vaccines For Children Industry Trends
  2. 2.2 Vaccines For Children Industry Drivers
  3. 2.3 Vaccines For Children Industry Opportunities and Challenges
  4. 2.4 Vaccines For Children Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vaccines For Children Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vaccines For Children Revenue by Region
  3. 3.2.1 Global Vaccines For Children Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vaccines For Children Revenue by Region (2021-2026)
  5. 3.2.3 Global Vaccines For Children Revenue by Region (2027-2032)
  6. 3.2.4 Global Vaccines For Children Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vaccines For Children Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vaccines For Children Sales by Region
  9. 3.4.1 Global Vaccines For Children Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vaccines For Children Sales by Region (2021-2026)
  11. 3.4.3 Global Vaccines For Children Sales by Region (2027-2032)
  12. 3.4.4 Global Vaccines For Children Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vaccines For Children Revenue by Manufacturers
  2. 4.1.1 Global Vaccines For Children Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vaccines For Children Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vaccines For Children Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vaccines For Children Sales by Manufacturers
  6. 4.2.1 Global Vaccines For Children Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vaccines For Children Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vaccines For Children Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vaccines For Children Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vaccines For Children Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vaccines For Children Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vaccines For Children Manufacturers, Product Type & Application
  13. 4.7 Global Vaccines For Children Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vaccines For Children Market CR5 and HHI
  16. 4.8.2 2025 Vaccines For Children Tier 1, Tier 2, and Tier 3
5 Vaccines For Children Market by Type
  1. 5.1 Global Vaccines For Children Revenue by Type
  2. 5.1.1 Global Vaccines For Children Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vaccines For Children Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vaccines For Children Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vaccines For Children Sales by Type
  6. 5.2.1 Global Vaccines For Children Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vaccines For Children Sales by Type (2021-2032) & (K Doses)
  8. 5.2.3 Global Vaccines For Children Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vaccines For Children Price by Type
6 Vaccines For Children Market by Application
  1. 6.1 Global Vaccines For Children Revenue by Application
  2. 6.1.1 Global Vaccines For Children Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vaccines For Children Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vaccines For Children Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vaccines For Children Sales by Application
  6. 6.2.1 Global Vaccines For Children Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vaccines For Children Sales by Application (2021-2032) & (K Doses)
  8. 6.2.3 Global Vaccines For Children Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vaccines For Children Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Vaccines For Children Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 CSL
  8. 7.2.1 CSL Company Information
  9. 7.2.2 CSL Business Overview
  10. 7.2.3 CSL Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSL Vaccines For Children Product Portfolio
  12. 7.2.5 CSL Recent Developments
  13. 7.3 Hissen
  14. 7.3.1 Hissen Company Information
  15. 7.3.2 Hissen Business Overview
  16. 7.3.3 Hissen Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hissen Vaccines For Children Product Portfolio
  18. 7.3.5 Hissen Recent Developments
  19. 7.4 J&J(Crucell)
  20. 7.4.1 J&J(Crucell) Company Information
  21. 7.4.2 J&J(Crucell) Business Overview
  22. 7.4.3 J&J(Crucell) Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 J&J(Crucell) Vaccines For Children Product Portfolio
  24. 7.4.5 J&J(Crucell) Recent Developments
  25. 7.5 Jintan
  26. 7.5.1 Jintan Company Information
  27. 7.5.2 Jintan Business Overview
  28. 7.5.3 Jintan Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jintan Vaccines For Children Product Portfolio
  30. 7.5.5 Jintan Recent Developments
  31. 7.6 MedImmune LLC
  32. 7.6.1 MedImmune LLC Company Information
  33. 7.6.2 MedImmune LLC Business Overview
  34. 7.6.3 MedImmune LLC Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 MedImmune LLC Vaccines For Children Product Portfolio
  36. 7.6.5 MedImmune LLC Recent Developments
  37. 7.7 Tiantan
  38. 7.7.1 Tiantan Company Information
  39. 7.7.2 Tiantan Business Overview
  40. 7.7.3 Tiantan Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Tiantan Vaccines For Children Product Portfolio
  42. 7.7.5 Tiantan Recent Developments
  43. 7.8 Hualan
  44. 7.8.1 Hualan Company Information
  45. 7.8.2 Hualan Business Overview
  46. 7.8.3 Hualan Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hualan Vaccines For Children Product Portfolio
  48. 7.8.5 Hualan Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Vaccines For Children Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 Kangtai
  56. 7.10.1 Kangtai Company Information
  57. 7.10.2 Kangtai Business Overview
  58. 7.10.3 Kangtai Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Kangtai Vaccines For Children Product Portfolio
  60. 7.10.5 Kangtai Recent Developments
  61. 7.11 Merck
  62. 7.11.1 Merck Company Information
  63. 7.11.2 Merck Business Overview
  64. 7.11.3 Merck Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Merck Vaccines For Children Product Portfolio
  66. 7.11.5 Merck Recent Developments
  67. 7.12 Sanofi
  68. 7.12.1 Sanofi Company Information
  69. 7.12.2 Sanofi Business Overview
  70. 7.12.3 Sanofi Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sanofi Vaccines For Children Product Portfolio
  72. 7.12.5 Sanofi Recent Developments
  73. 7.13 China National Biotec
  74. 7.13.1 China National Biotec Company Information
  75. 7.13.2 China National Biotec Business Overview
  76. 7.13.3 China National Biotec Vaccines For Children Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 China National Biotec Vaccines For Children Product Portfolio
  78. 7.13.5 China National Biotec Recent Developments
8 North America
  1. 8.1 North America Vaccines For Children Market Size by Type
  2. 8.1.1 North America Vaccines For Children Revenue by Type (2021-2032)
  3. 8.1.2 North America Vaccines For Children Sales by Type (2021-2032)
  4. 8.1.3 North America Vaccines For Children Price by Type (2021-2032)
  5. 8.2 North America Vaccines For Children Market Size by Application
  6. 8.2.1 North America Vaccines For Children Revenue by Application (2021-2032)
  7. 8.2.2 North America Vaccines For Children Sales by Application (2021-2032)
  8. 8.2.3 North America Vaccines For Children Price by Application (2021-2032)
  9. 8.3 North America Vaccines For Children Market Size by Country
  10. 8.3.1 North America Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vaccines For Children Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vaccines For Children Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Vaccines For Children Market Size by Type
  2. 9.1.1 Europe Vaccines For Children Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vaccines For Children Sales by Type (2021-2032)
  4. 9.1.3 Europe Vaccines For Children Price by Type (2021-2032)
  5. 9.2 Europe Vaccines For Children Market Size by Application
  6. 9.2.1 Europe Vaccines For Children Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vaccines For Children Sales by Application (2021-2032)
  8. 9.2.3 Europe Vaccines For Children Price by Application (2021-2032)
  9. 9.3 Europe Vaccines For Children Market Size by Country
  10. 9.3.1 Europe Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vaccines For Children Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vaccines For Children Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Vaccines For Children Market Size by Type
  2. 10.1.1 China Vaccines For Children Revenue by Type (2021-2032)
  3. 10.1.2 China Vaccines For Children Sales by Type (2021-2032)
  4. 10.1.3 China Vaccines For Children Price by Type (2021-2032)
  5. 10.2 China Vaccines For Children Market Size by Application
  6. 10.2.1 China Vaccines For Children Revenue by Application (2021-2032)
  7. 10.2.2 China Vaccines For Children Sales by Application (2021-2032)
  8. 10.2.3 China Vaccines For Children Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vaccines For Children Market Size by Type
  2. 11.1.1 Asia Vaccines For Children Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vaccines For Children Sales by Type (2021-2032)
  4. 11.1.3 Asia Vaccines For Children Price by Type (2021-2032)
  5. 11.2 Asia Vaccines For Children Market Size by Application
  6. 11.2.1 Asia Vaccines For Children Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vaccines For Children Sales by Application (2021-2032)
  8. 11.2.3 Asia Vaccines For Children Price by Application (2021-2032)
  9. 11.3 Asia Vaccines For Children Market Size by Country
  10. 11.3.1 Asia Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vaccines For Children Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vaccines For Children Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vaccines For Children Market Size by Type
  2. 12.1.1 SAMEA Vaccines For Children Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vaccines For Children Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vaccines For Children Price by Type (2021-2032)
  5. 12.2 SAMEA Vaccines For Children Market Size by Application
  6. 12.2.1 SAMEA Vaccines For Children Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vaccines For Children Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vaccines For Children Price by Application (2021-2032)
  9. 12.3 SAMEA Vaccines For Children Market Size by Country
  10. 12.3.1 SAMEA Vaccines For Children Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vaccines For Children Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vaccines For Children Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vaccines For Children Value Chain Analysis
  2. 13.1.1 Vaccines For Children Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vaccines For Children Production Mode & Process
  6. 13.2 Vaccines For Children Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vaccines For Children Distributors
  9. 13.2.3 Vaccines For Children Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst